TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
COLL

Collegium Pharmaceutical Inc

Healthcare · Drug Manufacturers - Specialty & Generic

23.80$ -1.0% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Collegium Pharmaceutical Inc (COLL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.4% of the shares are freely tradable; institutional investors hold 127.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 127.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 19.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 33Mio.

Largest Shareholders

Institutions

Institutions COLL
Name Stake (%) Shares Change (%) Date
BlackRock Inc 16.71 5,441,202 +6.0 06/30/2026
Jupiter Topco LLC 6.60 2,147,072 +0.0 06/30/2026
Amvescap Plc. 5.78 1,882,499 +18.3 06/30/2026
HHG PLC 5.61 1,825,651 +26.0 03/31/2026
Fuller & Thaler Asset Management Inc 5.02 1,632,781 +8.9 06/30/2026
Principal Financial Group Inc 5.01 1,632,360 +26.0 06/30/2026
State Street Corp 4.70 1,528,881 +7.3 06/30/2026
Massachusetts Financial Services Company 4.32 1,405,567 +2.9 06/30/2026

Funds

Funds COLL
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 5.95 1,937,273 +0.0 09/30/2026
FullerThaler Behavioral Sm-Cp Eq R6 4.80 1,561,408 +9.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?